Endo Pharmaceuticals, have agreed to pay $192.7 million to resolve criminal and civil allegations that it misbranded and promoted the use of an adhesive pain patch, Lidoderm, for alleviating pain from shingles (<a href=Photo via ShutterStock) " title="ssbackpainx1200" width="1" height="1"/>

Endo to pay $192.7 million to resolve off-label marketing claims

Endo Health Solutions and its subsidiary Endo Pharmaceuticals, based in Malvern, Pennsylvania, have agreed to pay $192.7 million to resol ...

12 years ago